{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:22Z","timestamp":1786979962369,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00296-019-04475-6","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T10:02:41Z","timestamp":1574416961000},"page":"1029-1035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Burden and management of gout in a multi-ethnic Asian cohort"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6252-1704","authenticated-orcid":false,"given":"Cheryl K. T.","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-7847","authenticated-orcid":false,"given":"Peter P.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2973-0798","authenticated-orcid":false,"given":"Amelia","family":"Santosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8227-6016","authenticated-orcid":false,"given":"Anita Y. N.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-5780","authenticated-orcid":false,"given":"Gim Gee","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"4475_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649\u2013662. https:\/\/doi.org\/10.1038\/nrrheum.2015.91","journal-title":"Nat Rev Rheumatol"},{"key":"4475_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/ard.2011.200523","volume":"71","author":"GG Teng","year":"2012","unstructured":"Teng GG, Ang LW, Saag KG et al (2012) Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Ann Rheum Dis 71:924\u2013928. https:\/\/doi.org\/10.1136\/ard.2011.200523","journal-title":"Ann Rheum Dis"},{"key":"4475_CR3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/rheumatology\/kem150","volume":"46","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M (2007) Is gout associated with reduced quality of life? A case\u2013control study. Rheumatology 46:1441\u20131444","journal-title":"Rheumatology"},{"key":"4475_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar3199","volume":"12","author":"E Roddy","year":"2010","unstructured":"Roddy E, Doherty M (2010) Gout. Epidemiology of gout. Arthritis Res Ther 12:223. https:\/\/doi.org\/10.1186\/ar3199","journal-title":"Arthritis Res Ther"},{"key":"4475_CR5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/ard.2007.081604","volume":"67","author":"JA Singh","year":"2008","unstructured":"Singh JA, Strand V (2008) Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 67:1306\u20131310. https:\/\/doi.org\/10.1136\/ard.2007.081604","journal-title":"Ann Rheum Dis"},{"key":"4475_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/rheumatology\/kep047","volume":"48","author":"SJ Lee","year":"2009","unstructured":"Lee SJ, Hirsch JD, Terkeltaub R et al (2009) Perceptions of disease and health-related quality of life among patients with gout. Rheumatology 48:582\u2013586. https:\/\/doi.org\/10.1093\/rheumatology\/kep047","journal-title":"Rheumatology"},{"key":"4475_CR7","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1136\/annrheumdis-2013-204647","volume":"73","author":"E Smith","year":"2014","unstructured":"Smith E, Hoy D, Cross M et al (2014) The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 73:1470\u20131476. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204647","journal-title":"Ann Rheum Dis"},{"key":"4475_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/1054773818769219","author":"LL Seow","year":"2018","unstructured":"Seow LL, Jiao N, Wang W et al (2018) A qualitative study exploring perceptions of patients with gout. Clin Nurs Res. https:\/\/doi.org\/10.1177\/1054773818769219","journal-title":"Clin Nurs Res"},{"key":"4475_CR9","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.23007","volume":"57","author":"F Perez-Ruiz","year":"2007","unstructured":"Perez-Ruiz F, Liot\u00e9 F (2007) Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? Arthritis Rheum 57:1324\u20131328. https:\/\/doi.org\/10.1002\/art.23007","journal-title":"Arthritis Rheum"},{"key":"4475_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.080814","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, MacDonald PA et al (2009) Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol 36:1273\u20131282. https:\/\/doi.org\/10.3899\/jrheum.080814","journal-title":"J Rheumatol"},{"key":"4475_CR11","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, FitzGerald JD, Khanna PP et al (2012) 2012 American College of Rheumatology Guidelines for Management of Gout Part I: systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 64:1431\u20131446. https:\/\/doi.org\/10.1002\/acr.21772","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4475_CR12","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.3899\/jrheum.090370","volume":"36","author":"HR Schumacher","year":"2009","unstructured":"Schumacher HR, Taylor W, Edwards L et al (2009) Outcome domains for studies of acute and chronic gout. J Rheumatol 36:2342\u20132345. https:\/\/doi.org\/10.3899\/jrheum.090370","journal-title":"J Rheumatol"},{"key":"4475_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2296-14-170","volume":"14","author":"E Cottrell","year":"2013","unstructured":"Cottrell E, Crabtree V, Edwards JJ, Roddy E (2013) Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Fam Pr 14:170. https:\/\/doi.org\/10.1186\/1471-2296-14-170","journal-title":"BMC Fam Pr"},{"key":"4475_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3109\/03009742.2012.689325","volume":"41","author":"AYN Lim","year":"2012","unstructured":"Lim AYN, Shen L, Tan CH et al (2012) Achieving treat to target in gout: a clinical practice improvement project. Scand J Rheumatol 41:450\u2013457. https:\/\/doi.org\/10.3109\/03009742.2012.689325","journal-title":"Scand J Rheumatol"},{"key":"4475_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/acr.21837","volume":"65","author":"R Garg","year":"2013","unstructured":"Garg R, Sayles HR, Yu F et al (2013) Gout-related health care utilization in US emergency departments, 2006 through 2008. Arthritis Care Res 65:571\u2013577. https:\/\/doi.org\/10.1002\/acr.21837","journal-title":"Arthritis Care Res"},{"key":"4475_CR16","first-page":"S145","volume":"30","author":"L Trieste","year":"2012","unstructured":"Trieste L, Palla I, Fusco F et al (2012) The economic impact of gout: a systematic literature review. Clin Exp Rheumatol 30:S145\u2013148","journal-title":"Clin Exp Rheumatol"},{"key":"4475_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.clinthera.2012.01.020","volume":"34","author":"H Park","year":"2012","unstructured":"Park H, Rascati KL, Prasla K, McBayne T (2012) Evaluation of health care costs and utilization patterns for patients with gout. Clin Ther 34:640\u2013652. https:\/\/doi.org\/10.1016\/j.clinthera.2012.01.020","journal-title":"Clin Ther"},{"key":"4475_CR18","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1111\/jocn.13918","volume":"27","author":"XHJ Chua","year":"2018","unstructured":"Chua XHJ, Lim S, Lim FP et al (2018) Factors influencing medication adherence in patients with gout: a descriptive correlational study. J Clin Nurs 27:e213\u2013e222. https:\/\/doi.org\/10.1111\/jocn.13918","journal-title":"J Clin Nurs"},{"key":"4475_CR19","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","volume":"71","author":"K Spencer","year":"2012","unstructured":"Spencer K, Carr A, Doherty M (2012) Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis 71:1490\u20131495. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200801","journal-title":"Ann Rheum Dis"},{"key":"4475_CR20","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/ard.2007.070755","volume":"66","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M (2007) Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 66:1311\u20131315","journal-title":"Ann Rheum Dis"},{"key":"4475_CR21","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1002\/acr.20622","volume":"63","author":"WJ Taylor","year":"2011","unstructured":"Taylor WJ (2011) Gout measures: Gout Assessment Questionnaire (GAQ, GAQ2.0), and physical measurement of tophi. Arthritis Care Res 63:S59\u201363. https:\/\/doi.org\/10.1002\/acr.20622","journal-title":"Arthritis Care Res"},{"key":"4475_CR22","unstructured":"KDIGO (2013) KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO_2012_CKD_GL.pdf.\u00a0Accessed 6 Oct 2018"},{"key":"4475_CR23","unstructured":"CDC (2015) Body Mass Index. https:\/\/www.cdc.gov\/healthyweight\/assessing\/bmi\/index.html.\u00a0Accessed 6 Oct 2018"},{"key":"4475_CR24","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/acr.20479","volume":"63","author":"MA DeMarco","year":"2011","unstructured":"DeMarco MA, Maynard JW, Huizinga MM et al (2011) Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res 63:1108\u20131114. https:\/\/doi.org\/10.1002\/acr.20479","journal-title":"Arthritis Care Res"},{"key":"4475_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/rheumatology\/keg035","volume":"42","author":"KH Yu","year":"2003","unstructured":"Yu KH, Luo SF (2003) Younger age of onset of gout in Taiwan. Rheumatology 42:166\u2013170","journal-title":"Rheumatology"},{"key":"4475_CR26","unstructured":"World Health Organization (2014) Global status report on alcohol and health 2014 - Individual Country Profiles. https:\/\/www.who.int\/substance_abuse\/publications\/global_alcohol_report\/msb_gsr_2014_2.pdf?ua=1&ua=1.\u00a0Accessed 6 Oct 2018"},{"key":"4475_CR27","unstructured":"Ministry of Health (Singapore) (2017) Disease Burden. https:\/\/www.moh.gov.sg\/content\/moh_web\/home\/statistics\/Health_Facts_Singapore\/Disease_Burden.html.\u00a0Accessed 6 Oct 2018"},{"key":"4475_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","volume":"75","author":"CF Kuo","year":"2016","unstructured":"Kuo CF, Grainge MJ, Mallen C et al (2016) Comorbidities in patients with gout prior to and following diagnosis: case\u2013control study. Ann Rheum Dis 75:210\u2013217. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206410","journal-title":"Ann Rheum Dis"},{"key":"4475_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med 125:679\u2013687. https:\/\/doi.org\/10.1016\/j.amjmed.2011.09.033","journal-title":"Am J Med"},{"key":"4475_CR30","doi-asserted-by":"publisher","first-page":"25766","DOI":"10.1038\/srep25766","volume":"6","author":"A Pan","year":"2016","unstructured":"Pan A, Teng GG, Yuan JM, Koh WP (2016) Bidirectional association between diabetes and gout: the Singapore Chinese Health Study. Sci Rep 6:25766. https:\/\/doi.org\/10.1038\/srep25766","journal-title":"Sci Rep"},{"key":"4475_CR31","doi-asserted-by":"publisher","first-page":"e0141749","DOI":"10.1371\/journal.pone.0141749","volume":"10","author":"A Pan","year":"2015","unstructured":"Pan A, Teng GG, Yuan J-M, Koh W-P (2015) Bidirectional association between self-reported hypertension and gout: the Singapore Chinese Health Study. PLoS ONE 10:e0141749. https:\/\/doi.org\/10.1371\/journal.pone.0141749","journal-title":"PLoS ONE"},{"key":"4475_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57:109\u2013115","journal-title":"Arthritis Rheum"},{"key":"4475_CR33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","volume":"120","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES (2007) Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120:442\u2013447","journal-title":"Am J Med"},{"key":"4475_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/SMJ.0000000000000082","volume":"107","author":"E Karis","year":"2014","unstructured":"Karis E, Crittenden DB, Pillinger MH (2014) Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street. South Med J 107:235\u2013241. https:\/\/doi.org\/10.1097\/SMJ.0000000000000082","journal-title":"South Med J"},{"key":"4475_CR35","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3899\/jrheum.080487","volume":"36","author":"EQ Wu","year":"2009","unstructured":"Wu EQ, Patel PA, Mody RR et al (2009) Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol 36:1032\u20131040. https:\/\/doi.org\/10.3899\/jrheum.080487","journal-title":"J Rheumatol"},{"key":"4475_CR36","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/MJT.0b013e31820543c5","volume":"19","author":"EQ Wu","year":"2012","unstructured":"Wu EQ, Forsythe A, Gu\u00e9rin A et al (2012) Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy. Am J Ther 19:e157\u2013166. https:\/\/doi.org\/10.1097\/MJT.0b013e31820543c5","journal-title":"Am J Ther"},{"key":"4475_CR37","unstructured":"Singapore Department of Statistics (2018) M850581\u2014Singapore Residents Aged 25 Years & Over By Highest Qualification Attained, Sex And Age Group, Annual. In: Educ. Lang. Spok. Lit. https:\/\/www.tablebuilder.singstat.gov.sg\/publicfacing\/createDataTable.action?refId=12078.\u00a0Accessed 6 Oct 2018"},{"key":"4475_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/RHU.0b013e3181b562f8","volume":"15","author":"I Hutton","year":"2009","unstructured":"Hutton I, Gamble G, Gow P, Dalbeth N (2009) Factors associated with recurrent hospital admissions for gout: a case-control study. J Clin Rheumatol 15:271\u2013274. https:\/\/doi.org\/10.1097\/RHU.0b013e3181b562f8","journal-title":"J Clin Rheumatol"},{"key":"4475_CR39","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/ar2659","volume":"11","author":"LR Harrold","year":"2009","unstructured":"Harrold LR, Andrade SE, Briesacher BA et al (2009) Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 11:R46. https:\/\/doi.org\/10.1186\/ar2659","journal-title":"Arthritis Res Ther"},{"key":"4475_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28:437\u2013443. https:\/\/doi.org\/10.1592\/phco.28.4.437","journal-title":"Pharmacotherapy"},{"key":"4475_CR41","first-page":"1575","volume":"31","author":"AA Riedel","year":"2004","unstructured":"Riedel AA, Nelson M, Joseph-Ridge N et al (2004) Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol 31:1575\u20131581","journal-title":"J Rheumatol"},{"key":"4475_CR42","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","volume":"66","author":"MA De Vera","year":"2014","unstructured":"De Vera MA, Marcotte G, Rai S et al (2014) Medication adherence in gout: a systematic review. Arthritis Care Res 66:1551\u20131559. https:\/\/doi.org\/10.1002\/acr.22336","journal-title":"Arthritis Care Res"},{"key":"4475_CR43","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/rheumatology\/kes431","volume":"52","author":"G Zandman-Goddard","year":"2013","unstructured":"Zandman-Goddard G, Amital H, Shamrayevsky N et al (2013) Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology 52:1126\u20131131. https:\/\/doi.org\/10.1093\/rheumatology\/kes431","journal-title":"Rheumatology"},{"key":"4475_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/ard.2007.076182","volume":"67","author":"DH Solomon","year":"2008","unstructured":"Solomon DH, Avorn J, Levin R, Brookhart MA (2008) Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis 67:609\u2013613","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04475-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T19:39:20Z","timestamp":1605901160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04475-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"21 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no financial disclosures and declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}